Диссертация (1146685), страница 20
Текст из файла (страница 20)
– 2012 Sep. – Vol 44(7). – P. 1876-8.154. Ding F, Ahrenholz P, Winkler E et al. Online hemodiafiltration versusacetate-free biofiltration: A prospective crossover study. Artificial Organs. –2002. – Vol 26. – P. 169-180.155. Donauer J, Schweiger C, Rumberger B, et al. Reduction of hypotensive sideeffects during online-haemodiafiltration and low temperature haemodialysis.Nephrol Dial Transplant.
– 2003. – Vol 18(8). – P. 1616-22.156. Dou L, Bertrand, Cerini C et al. The uremic solutes p-cresol and indoxylsulfate inhibit endothelial proliferation and wound repair. Kidney Int. – 2004. –Vol 62.65. – P. 442-451.157. Dou L, Cerini C, Brunet P et al. P-cresol, a uremic toxin decreasesendothelial cell response to inflammatory cytokines.
Kidney Int. – 2002. – Vol62. – P. 1999-2009.158. Druecke TB, Khao TN, Massy ZA, et al. Role of oxidised low-densitylipoprotein in the atherosclerosis of uremia. Kid Int. – 2001. – Vol 59 (Suppl78). – P. S114-S119.159. Drummond A.E.R. Development and validation of the Nottingham LeisureQuestionnaire (NLQ) / A.E.R.
Drummond, C.J. Parker, J.R.F. Gladman, P.A.Logan // Clinical Rehabilitation. – 2001. – Vol. 15. – P. 647–656.160. Eisenberg L. A very British kind of social psychiatry / L. Eisenberg // Brit. J.Psychiatry. – 1977. – Vol. 171. – P. 309–313.161. Eschbach JW. The anemia of chronic renal failure: pathophysiology and theeffect of recombinant erythropoietin.
Kidney Int. – 1989. – Vol 35. – P. 134148.162. European best practice guidelines on haemodialysis // Nephrol. Dial.Transplant.–2007.–Vol. 22, suppl.2.–P. 45–87.163. Feroze U1, Martin D, Kalantar-Zadeh K, Kim JC, Reina-Patton A, KoppleJD. Anxiety and depression in maintenance dialysis patients: preliminary data120of a cross-sectional study and brief literature review. J Ren Nutr.
– 2012 Jan. –Vol 22(1). – P. 207-10.164. Floege J, Kettler M. beta-2-microglobulin-derived amyloidosis: an update.Kidney Int Suppl. – 2001. – Vol 78. – P. 164-171.165. Foley R N, Parfrey P S, Sarnak M J. Clinical epidemiology of cardiovasculardisease in chronic renal disease. Am J Kidney Dis. – 1998. – Vol 32 (5),Supplement 3. – P. S112-S119.166. Fried L, Bernardini/, Piraino B. Charlson comorbidity index as a predictor ofoutcomes in incident peritoneal dialysis patients. Am J Kidney Dis.
– 2001. –Vol 37. – P. 337-342.167. Fujisawa M., Ichikawa Y., Yoshiya K., Isotani S., Higuchi A., Nagano S.,Arakawa S., Hamami G., Matsumoto O., Kamidono S. Assessment of healthrelated quality of life in renal transplant and hemodialysis patients using theSF-36 health survey. Urology. – 2000 Aug 1.
– Vol 56(2). – P. 201-6.168. García-Llana H1, Remor E, Selgas R.Psicothema. Adherence to treatment,emotional state and quality of life in patients with end-stage renal diseaseundergoing dialysis. – 2013 Feb. – 25(1). – P. 79-86.169. Gerdemann A, Bahner U, Vienken J et al. Plasma levels of advancedglycation end products during haemodialysis, haemodiafiltration andhaemofiltration: potential importance of dialysate quality. Nephrol DialTransplant.
– 2002). – Vol. 17. – P. 1045-1049.170. Gibbons G H, Dzau VJ. The emerging concept of vascular modelling. NewEng J Med. – 1994. – Vol. 330(20). – P. 1431-1438.171. Gil C, Lucas C, Possante C et al. On-line haemodiafiltration decreases serumTNFalpha levels in haemodialyis patients. Nephrol Dial Transplant. – 2003. –Vol. 18. – P.
447-448.172. Goldberg IJ, Kaufman AM, Lavarias VA et al. High flux dialysismembranes improve plasma lipoprotein profiles in patients with endstage renaldisease. Nephrol Dial Transplant. – 1996. – Vol. 11. – P. 104-107.121173. Grimby G. The Functional Independence Measure in Sweden: experience foroutcome measurement in rehabilitation medicine / G. Grimby, M. Rodhe, K.S.Sunnerhagen et al. // Scand. J. Rehab.
Med. – 1996. – Vol. 28. – P. 51–62.174. Guerra-Guerrerro V, Plazas Mdel P, Cameron BL, Salas AV, González CG.Understanding the life experience of people on hemodialysis: adherence totreatment and quality of life. Nephrol Nurs J. – 2014 May-Jun. – Vol. 41(3). –P.289-97, 316; quiz 298.175. Hachinski V.C. Multiinfarct dementia. A case of mental deterioration in theelderly / V.C. Hachinski, N.A. Lassen, J. Marshall //Lancet. – 1974. – Vol.
2. –P. 207–210.176. Helmer C, Stengel B., Metzger M. et al. Chronic kidney disease, cognitivedecline, and incident dementia: the 3C Study. Neurology. – 2011. – Vol77(23). – P.2043-2051.177. Hemmelgarn BR, Manns BJV Quan H. et al. Adapting the CharlsonComorbidity Index for use in patients with ESRD. Am J Kidney Dis.
– 2003. –Vol 42. – P. 125-132.178. Hendrikus W, van Kuijk M, Leunissen KML. Hemodynamic Stabilityduring Different Forms of Dialysis Therapy: A Pathogenetic Analysis. BloodPurif. – 1996. – 14:405-420.179. Herman B.P. Quality of Life in epilepsy / B.P. Herman // J. Epilepsy. –1992.
– Vol. 5. – P. 153–165.180. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia:oxidant stress as a unifying concept for cardiovascular disease in uremia.Kidney Int. – 2002. – P. 1524-1538.181. Iborra-MoltóC, López-RoigS, Pastor-MiraMdeL.IntUrolNephrol. Prevalence of adherence to fluid restriction in kidney patients inhaemodialysis: objective indicator and perceived compliance. Nefrologia. –2012.
– Jul 17. – P. 477-85.122182. Jacek SM, Malyszko J, Hryszko T et al. Markers of endothelial damage inpatients on hemodialysis and hemodiafiltration. J Nephrol. – 2006. – P. 150154.183. Jacobsen S H, Egberg N, Hylander B, Lundahl, J. Correlation betweensoluble markers of endothelial dysfunction in patients with renal failure.
Am JNephrol. – 2002. – Vol. 22. – P. 42-47.184. Jain N., Trivedi M.H., Rush A.J. et al. Rationale and design of the ChronicKidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials.– 2012. – Vol 34(1). – P. 136-144.185. Jassal S.K., Kritz-Silverstein D., Barrett-Connor E. A Prospective Study ofAlbuminuria and Cognitive Function in Older Adults. Am. J. Epidemiol. –2010. – Vol 171(3). – P.
277-286.186. Jin J, Sklar G, Li SC. Factors affecting therapeutic compliance: a reviewfrom the patient’s perspective. Ther Clin Risk Manag. – 2008. – Vol 4. – P.269–86.187. Jirka T, Cesare S, Di Benedetto A et al. Mortality risk for patients receivingHDF versus Haemodialysis. Kid Int. – 2006. – Vol. 70. – P. 1524 (Letter to theeditor, in response to Canaud et al.
publication).188. John T. Daugirdas, Peter G. Blake, Todd S. Ing. Handbook of Dialysis. –2003. – P. 459-465.189. Kalousova M, Zima T, Tesar V et al. Advanced glycation end products inclinical nephrology. Kidney Blood Press Res. – 2004. – Vol. 27. – P. 18-28.190. Katz S. The index of ADL: a standardized measure of biological andpsychological function / S. Katz, A.
Ford, R. Moskowitz // Journal of theAmerican Medical Association. – 1963. – Vol. 185. – P. 914–919.191. Kawabata M, Kasuga S, Ogawa T et al. Peculiar blood volume profileduring hemodiafiltration therapy: of benefit to the hemodynamic stability inpatients? Clin Nephrol. – 1998. – Vol. 50. – P.
333-334.123192. Kimmel PL. Psychosocial factors in adult end-stage renal disease patientstreated with hemodialysis: correlates and outcomes. Am J Kidney Dis. – 2000Apr. – Vol. 35:4 Suppl 1. – P. S132-40.193. Kimmel PL., Peterson RA., Weihs KL., Simmens SJ. Aspects of quality oflife in hemodialysis patients. J Am Soc Nephrol. – 1995 Nov. – Vol. 6(5).
– P.1418-26.194. Kimmel PL., Peterson RA., Weihs KL., Simmens SJ. Psychosocial factors,behavioral compliance and survival in urban hemodialysis patients. Kidney Int.– 1998 Jul. – Vol. 54(1). – P. 245-54.195. Kooman JP, van der Sande FM, Beerenhout C M et al. On-Line FiltrationTherapies: Emerging Horizons. Blood Purif. – 2006.
– Vol. 24. – P. 159 –1621.196. Krane V, Wanner C. Cardiovascular disease and predisposing factors inchronic renal failure. National Kidney Foundation: K/DOQI Clinical PracticeGuidelines for Chronic Kidney Disease: Evaluation, Classification andStratification.
Executive Summary. Am J Kidney Dis. – 2002. – Vol. 39 (2)Suppl 1. – P. S17-S31.197. Kugoh Т. Quality of life in adult patients with epilepsy / T. Kugoh //Epilepsia. – 1996. – № 37 (Suppl. 3). – P. 37–40.198. Kurella Tamura M., Muntner P., Wadley V. et al. Albuminuria, KidneyFunction, and the Incidence of Cognitive Impairment AmongAdults in theUnited States. Am. J. Kidney Dis. – 2011. – Vol. 33(2). – P. S16-S30.199. Kuvin JT, Karas RH. Clinical utility of endothelial function testing.Circulation.
– 2003. – Vol. 107. – P. 3243-3247.200. Laidlaw JK., Beeken JE., Whitney FW., Reyes AA. Contracting withoutpatient hemodialysis patients to improve adherence to treatment. ANNA J. –1999 Feb. – Vol. 26:1. – P. 37-40.201. Landray MJ, Wheeler DC, Gregory YH et al. Inflammation, endothelialdysfunction, and platelet activation in patients with chronic kidney disease: the124Chronic Renal Impairment In Birmingham (CRIB) Study. Am J Kidney Dis. –2004.
– Vol. 43. – P. 244-253.202. Ledebo I. Convective Dialysis Therapies, Current Status and Perspective.International Society for Apheresis, Therapeutic Apheresis and Dialysis Am JKidney Dis. – 2005. – Vol. 42. – P. 234-243.203. Leggat JE Jr., Orzol SM., Hulbert., Shearon TE et al. Noncompliance inhemodialysis: predictors and survival analysis. Am J Kidney Dis. – 1998 Jul.
–Vol. 32:1. – P. 139-45.204. Lennihan L. Social concerns and discharge planning / L. Lennihan //Handbook of Neurorehabilitation / ed. by D.C. Good, J.R. Couch, Jr. – NewYork: Marcel Dekker, Inc., 1994. – P. 165–177.205. Leplege A. The problem of quality of life in medicine / A. Leplege, S. Hunt// JAMA. – 1997.
– Vol. 278. – P. 47–50.206. Leunissen KM, Kooman JP, van der Sande FM et al. Hypotension andultrafiltration physiology in dialysis. Blood Purif. – 2000. – Vol. 18. – P. 251254.207. Mailloux LU. Hypertension in the dialysis patient. Am J Kidney Dis. –1999. – Vol. 34. – P. 359-361.208. Leunissen KM, Kooman JP, van Kuijk W et al. Preventing haemodynamicinstability in patients at risk for intra-dialytic hypotension.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
